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Aging contributes to cellular stress and neurodegeneration. Our understanding is limited regarding the tissue-restricted mechanisms
providing protection in postmitotic cells throughout life. Here, we show that spinal cord motoneurons exhibit a high abundance of
asymmetric dimethyl arginines (ADMAs) and the presence of this posttranslational modification provides protection against environ-
mental stress. We identify protein arginine methyltransferase 8 (PRMT8) as a tissue-restricted enzyme responsible for proper ADMA
level inpostmitoticneurons.MalePRMT8knock-outmicedisplaydecreasedmuscle strengthwithagingdue toprematuredestabilization
of neuromuscular junctions. Mechanistically, inhibition of methyltransferase activity or loss of PRMT8 results in accumulation of
unrepaired DNA double-stranded breaks and decrease in the cAMP response-element-binding protein 1 (CREB1) level. As a conse-
quence, the expression of CREB1-mediated prosurvival and regeneration-associated immediate early genes is dysregulated in aging
PRMT8 knock-out mice. The uncovered role of PRMT8 represents a novel mechanism of stress tolerance in long-lived postmitotic
neurons and identifies PRMT8 as a tissue-specific therapeutic target in the prevention of motoneuron degeneration.
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Introduction
The rate of cellular aging and the appearance of age-related pathol-
ogies are modulated by highly conserved stress response and repair
pathways (Haigis andYankner, 2010). Accumulating evidence indi-
cates that the longevity of a cell or organismdepends on its ability to
properly regulate signaling pathways that counteract perturbations,
such as proteinmisfolding,DNAdamage, or oxidative stress (Kour-
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Significance Statement
Althoughmost of the cells in our body have a very short lifespan, postmitotic neurons must survive for many decades. Longevity
of a cell within the organism depends on its ability to properly regulate signaling pathways that counteract perturbations, such as
DNA damage, oxidative stress, or proteinmisfolding. Here, we provide evidence that tissue-specific regulators of stress tolerance
exist in postmitotic neurons. Specifically, we identify protein arginine methyltransferase 8 (PRMT8) as a cell-type-restricted
arginine methyltransferase in spinal cord motoneurons (MNs). PRMT8-dependent arginine methylation is required for neuro-
protection against age-related increasedof cellular stress. Tissue-restricted expression and the enzymatic activity of PRMT8make
it an attractive target for drug development to delay the onset of neurodegenerative disorders.
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tis and Tavernarakis, 2011). However, stress responses must funda-
mentally differ between proliferating cells, which can be easily
replaced, and cells that are terminally differentiated andnonreplace-
able, such as postmitotic neurons. In proliferating cells, the risk of
propagating cellular defects is great, which can be potentially threat-
ening the survival of the entire organism. Therefore, elimination of
damaged proliferating cells is the most straightforward solution. In
contrast, in long-lived neurons, this could damage the integrity of
the complex neural network, so alternative mechanisms need to be
used toproperlymaintain thehomeostasisof thesecells (Herrupand
Yang, 2007;Kole et al., 2013). Identifying andunderstandingmolec-
ular mechanisms regulating cellular stress resistance in postmitotic
neurons is important for defining novel therapeutic targets in late-
onset neurodegenerative diseases.
Posttranslational modifications (PTMs), such asmethylation,
acetylation, and phosphorylation are crucial for balanced func-
tions of stress response pathways and dysregulated PTMs can
potentially lead to a pathological state (Lake and Bedford, 2007;
Dantuma and van Attikum, 2016). Arginine is a positively
charged residue that is often found in protein motifs, including
the RGG/RG motifs (Thandapani et al., 2013). The RGG se-
quences within these motifs are substrate recognition sites for
type I and type II protein arginine methyltransferases (PRMTs)
catalyzingmonomethylation and asymmetric or symmetric dim-
ethylation of arginine residues, respectively (Bedford and Clarke,
2009; Blanc and Richard, 2017). In the last decade, hundreds of
methylarginine proteins have been detected by mass spectrome-
try and other proteomic and molecular techniques (Hart-Smith
et al., 2012; Bremang et al., 2013; Guo et al., 2014; Auburger et al.,
2016). Thesemethyltransferase substrate proteins are involved in
transcriptional regulation (TAF15, CRTC2), pre-mRNA splicing
(FUS, G3BP1, hnRNP A1, DDX3X, SAM68), mRNA translation
(EIF3, EIF4), DNA-damage response (MRE11, 53BP1, FUS), and
regulation of apoptosis (PABP1). Prior in vitro studies estab-
lished that asymmetric arginine dimethylation of amyotrophic
lateral sclerosis (ALS)-related FUS, TAF15, hnRNPA1, andmeth-
ylation of many others is required for adequate stress response
(Liu and Dreyfuss, 1995; Tradewell et al., 2012; Yamaguchi and
Kitajo, 2012; Shorter and Taylor, 2013). Other studies implicated
the involvement of arginine methylation in DNA damage re-
sponse through the methylation of MRE11 and 53BP1 (Boisvert
et al., 2005a,b). Together, these results strongly indicate a regula-
tory role for asymmetric argininemethylation in the regulation of
stress response of neurons and the pathogenesis of neurodegen-
erative diseases.
Thus far, 11 members of this enzyme family have been iden-
tified (Bedford and Clarke, 2009; Blanc and Richard, 2017).
PRMT8 is a uniquemember of the family because it shows highly
tissue-specific expression by being restricted to the CNS (Taneda
et al., 2007; Kousaka et al., 2009). PRMT8 has been shown to act
as a posttranslational modifier of various proteins (Kim et al.,
2008; Pahlich et al., 2008). Similar to PRMT1, its closest paralog,
PRMT8, is involved in the epigenetic control of gene expression
and normal function of neurons (Simandi et al., 2015). However,
the in vivo biological role of PRMT8 in the CNS and the mecha-
nisms resulting in neural defects remain largely unknown except
for very recent studies that described the role of PRMT8 in Pur-
kinje cells (Kim et al., 2015) and excitatory synaptic function
(Penney et al., 2017).
Here, we show that asymmetric dimethyl arginine (ADMA)
level declines during embryonic development in the mouse.
Strikingly, choline acetyltransferase (ChAT) MNs selectively
maintain high ADMA level in the adult spinal cord. Fused in
sarcoma (FUS), a prominent arginine methyltransferase target,
shows similar cell-type-restricted expression. Inhibition ofmeth-
yltransferases results in accumulation of DNA double-stranded
breaks (DSBs), altered FUS kinetics at DNA DSBs, and overall a
more vulnerable cellular state and decreased cellular viability.We
show that, among the asymmetric arginine methyltransferases,
PRMT8 is selectively expressed in the spinal cord MNs. Loss of
PRMT8 results in a progressive decrease in muscle strength due to
the dysfunction and gradual loss ofMNs in aging animals. The per-
sistent stress in the absence of methyltransferase activity leads to
decreasedcAMPresponse-element-bindingprotein1(CREB1) level
and insufficient activation of prosurvival and regeneration gene net-
work in response to aging-related oxidative andER stress. Thiswork
is a proof-of-concept showing that ADMA has a nonproliferation-
associated, cell-type-restricted role and is required for proper stress
response in postmitotic neurons. Based on our findings, PRMT8
should be considered as a novel component of neural stress resis-
tance and a target for future drug discovery in neurodegenerative
diseases.
Materials andMethods
Cell culture. Undifferentiated NSC34 cells were maintained in prolifera-
tion media (DMEM, 10% FBS, 1% antibiotics). For differentiation, cells
were seeded at a concentration of 5000 cells/cm2 and, 24 h after plating,
medium was changed to differentiation medium (1:1 DMEM/F12, 1%
FBS, 1% nonessential amino acid, and 1M all-trans retinoic acid). Cells
were allowed to differentiate up to 4 d and differentiation medium was
changed on the second day. Differentiated cells were treated with stress
inducers for 3 h before RNA isolation and 12 h for immunoblot analysis.
Endoplasmic Reticulum (ER) stress was induced by thapsigargin (Milli-
pore) in a 0.2 M (cell viability assay) or 1 M (gene expression, protein
analysis) final concentration. Sodium arsenite (Sigma-Aldrich) was used
in a 0.1M (cell viability assay) or 10M concentration (gene expression,
protein analysis) to induce oxidative stress. ADOX (Sigma-Aldrich) was
used in a 40 M final concentration. Human induced pluripotent stem
cells (iPSCs) were differentiated to motoneurons (MNs) stress as de-
scribed previously (Das et al., 2007).
Gene-silencing assays. siRNA constructs were purchased from Sigma-
Aldrich for targeting the mouse Creb1 (Mm02_00289365) and Prmt8
(Mm01_00128129). MISSION siRNA fluorescent universal negative
control #1 (Sigma-Aldrich) was used as a control. NSC34 cells were
plated and differentiated 2 d before transfection. Transfection of NSC34
cells was performed using Lipofectamine 3000 transfection reagent
(Thermo Fisher Scientific) according to themanufacturer’s instructions.
Mice. The PRMT8-null mouse line was generated by the European
Conditional Mouse Mutagenesis Program and Knockout Mouse
Project (EUCOMM/KOMP) and Sanger Mouse Genetics Project
(EPD0105_1_A03) and was purchased from the European Mouse Mutant
Archive (EM:04479). For genotyping of PRMT8 knock-out mice, tail DNA
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was extracted and multiplex allele-specific PCR was performed using the
followingPCRprimers: forward (P1), 5-CCTGGCACTTTGAGGTGTTG-
3, andreverse (P2), 5-GTCTGATGGAATGGGCCTG-3,whichgenerated
a 380 bp product for the Prmt8 wild-type allele; and reverse (P3), 5-
TCGTGGTATCGTTATGCGCC-3, which generated a 252 bp product for
the Prmt8 knock-out allele. Male mice were used for the experiments.
Onset ages of the disease in G93A SOD1-transgenic mice were deter-
mined as the time when the animals reached peak body weight and the
end stage of the disease were determined when the animals could not
right themselves within 10 s when placed on their side, typically12–15
weeks of age.
Animals that underwent surgical maneuvers (both recovery and ter-
minal surgeries) were anesthetized with ketamine–xylazine combined
intramuscular anesthesia as follows: ketamine hydcrochloride (Ketavet;
Pharmacia &Upjohn) at 110mg/kg body weight and xylazine (Rompun;
Bayer) at 12 mg/kg body weight.
Grip strength, Rotarod, and limb clasping. Phenotyping characteriza-
tion was performed in the Department of Behavioral Neurobiology (In-
stitute of ExperimentalMedicine of theHungarian Academy of Sciences,
Budapest, Hungary). For grip strength measurement, animals were held
by the base of the tail and allowed to grasp a steel grip gauge (2mm) with
their forepaws. Then, the mice were gently pulled away from the grip
gauges in a steady fashion until the grip was released. The force exerted at
the gauge at the time of grip release is determined by themouse itself and
is recorded as the grip force. At each time point, forelimb forces were the
average of five measurements.
For the accelerating Rotarod test, the rotating rod apparatus (ITC Life
Science) was used tomeasure themotor coordination and ability of mice
to improvemotor skill performance with training.Mice were placed on a
rod and the rod was accelerated from 0 to 45 rpm in 2 min. The time
periods that individual mice spent on the rod without falling were re-
corded. Three trials with a 30 min intertrial interval were performed
every day for 3 d. Hindlimb position forelimb clasping was observed and
scored as described by Guyenet et al. (2010).
Muscle tension recording. Animals that were 3, 6, and 12 months old
were randomly selected for tension recording (n 5 in both the control
and the knock-out groups) and anesthetized with ketamine–xylazine at
the 3, 6, and 12months survival period and the tibialis anterior (TA) and
extensor digitorum longus (EDL)muscles of hindlimbwere prepared for
tension recording. The distal tendons were dissected free and attached to
strain gauges and the exposed parts of the muscles were kept moist with
Krebs’ saline solution. Isometric contractions were then elicited from the
muscles by stimulating the common peroneal nerve with bipolar elec-
trodes. The length of each muscle was adjusted so as to produce the
maximum twitch tension. Single twitch and tetanic (40–100 Hz) con-
tractions were displayed and recorded on a computer; all the additional
recording hardware and software were developed by Supertech (Kelle´nyi
system). Maximum tetanic tension was achieved at a stimulation fre-
quency of100 Hz. An estimate of the numbers of motor axons supply-
ing themuscles was obtained by stimulating the common peroneal nerve
with stimuli of increasing intensity and recording the stepwise incre-
ments of twitch contractions.
Force measurements in single myocyte preparations. Force development
during isometric contractions wasmeasured in fast skeletal muscle fibers
from EDL muscles of 3- and 12-month-old control and PRMT8-null
mice. Permeabilized EDL myocytes were mounted between two thin
needles with silicone adhesive and viewed under an invertedmicroscope.
One needle was attached to a force transducer and the other to an elec-
tromagnetic motor. The measurements were performed at 15°C and the
average sarcomere length was adjusted to 2.3m. The generation of total
isometric force production was measured at saturating Ca2 concentra-
tion (pCa 4.75). When a steady force level was reached, myocyte length
was reduced by 20%within 2ms and then quickly restretched. As a result,
the force first dropped from the peak isometric level to zero (difference
maximal Ca2-activated force) and then started to redevelop. After 8 s of
force redevelopment, themyocytewas transferred into the relaxing solution.
Maximal Ca2-activated force was normalized to cross-sectional area.
Muscle histochemistry. Motor end plates and their axons were visual-
ized by using a combined silver impregnation and acetylcholine esterase
histochemistry as described previously (Namba et al., 1967).
Retrograde labeling. The operations were performed under deep ket-
amine–xylazine anesthesia as described above using sterile procedures.
On the left side, the sciatic nervewas sectioned and the proximal stumpof
the nerve was covered with a few Fast Blue crystals. Five animals per
group were used (from 6- and 12-month-old control and the knock-out
groups). Four days after the application of this fluorescent dye, the ani-
mals were reanesthetized and perfused transcardially with 4% parafor-
maldehyde in 0.1 mol/L phosphate buffer, pH 7.4.
Quantification of motor fibers of the L4 ventral root. Semithin sections
were cut fromL4 ventral root (n 5 in each group). Remnants of fixative
were carefully washed out from the root and the tissue was treated in 1%
OsO4 (Agar Scientific) in PBS for 1 h, dehydrated in a graded ethanol
series and propylene oxide, and then embedded in Durcupan (Fluka).
Semithin sections (0.5 m) were cut from the L4 ventral root on a Leica
Ultracut-R ultramicrotome. Images of the whole cross-sectional area of
the nerve were taken with an Olympus DP70 camera attached to an
Olympus BX-50 microscope. Myelinated fibers were counted with the
aid of ImageJ image analysis software.Myelinated axons displaying path-
ological alterations were not included in the axon counts.
Cell counts and quantification of neuromuscular junction (NMJ) patho-
logical alterations. The numbers of retrograde labeled cells and/or
anti-vesicular acetylcholine transporter (VAChT)-positive cells were de-
termined on 25-m-thick serial cryostat sections. To avoid double
counting of neurons present in consecutive sections, the retrograde la-
beled neurons andVAChTMNsweremappedwith the aid of anOlym-
pus drawing tube and their locations compared with those of the labeled
neurons in the previous section (No´gra´di et al., 2007; Pinte´r et al., 2010).
To analyze the denervated NMJ structures, every third longitudinal
section of TA and EDL muscles processed for a combined silver–acetyl-
cholinesterase histochemistry were mounted onto gelatin-coated glass
slides. Morphological characterization of NMJ changes was scored based
according to recent studies (Bruneteau et al., 2015) and (Valdez et al.,
2010). Normal NMJs have a normal postsynaptic apparatus and a termi-
nal arborization of the axon on the presynaptic side. Fragmented NMJs
are marked by their structure broken up into three or more fragments.
Hypertrophic NMJs were characterized by enlarged postsynaptic ele-
ments. Flattened NMJs were faintly visible and the area of NMJ was
flattened and considerably decreased. The unclassified group of NMJs
contains those motor end plates that could not be classified into any of
the above groups.
In intact muscles, subterminal axons running to a NMJ do not divide.
Sprouts develop when the axon supplying amotor end plate splits before
innervating the NMJ (preterminal sprout) or beyond the NMJ (ultrater-
minal sprout) in any direction. Preterminal and ultraterminal sproutings
were determined in 6- and 12-month-old PRMT8-null mice by counting
the sprouts in every third section containing the innervations zone of TA
and EDL muscles.
Electron microscopy. Experiments were performed on 3- and 12-
month-old PRMT8 knock-out and wild-type mice. The animals were
deeply anesthetizedwith sodiumpentobarbital (50mg/kg, i.p.) and tran-
scardially perfused first with Tyrode’s solution (oxygenated with a mix-
ture of 95% O2, 5% CO2), followed by a fixative containing 2.5%
glutaraldehyde, 0.5% paraformaldehyde, and 0.2% picric acid dissolved
in 0.1 M phosphate buffer (PB, pH 7.4). The L3–L5 segments of the spinal
cord, the L4 ventral root, the sciatic and phrenic nerves, and the TA and
EDL muscles were removed and postfixed in the same fixative for 1–2 h.
Following extensive washes in 0.1 M phosphate buffer, the tissue blocks
were treated with 1% OsO4 for 1 h and then dehydrated and embedded
into Durcupan ACM resin (catalog #44610-1EA; Sigma-Aldrich). Ultra-
thin sections were cut, collected on Formwar-coated single-slot grids,
and counterstained with uranyl acetate and lead citrate. Sections were
investigated in JEOL JEM 1010 transmission electron microscope and
photographed with an Olympus Veleta slow scan cooled CCD camera.
Images were stored in an IBM PC and processed with Adobe Photoshop
CS5 software (SciRes_000161).
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PRMT8 antibodies. Cellular localization of endogenous PRMT8 has
been debated due to the lack of a specific antibody (Lee et al., 2005;
Kousaka et al., 2009). In this work, we used three antibodies. P90742
PP1/PP13 rabbit polyclonal antibodies were developed by Cell Signaling
Technology and used for immunoblotting only.
We also developed a new antibody for immunohistochemical detec-
tion of PRMT8. Briefly, the synthetic gene encoding for the N-terminal
amino acids (Ala2-Glu55, AENAVESTEVSSAPPQPPQPVIPAKPVQ
CVHHVSTQPSCPGRGKMSKLLNPEE, mPRMT8-54) was subcloned
into pUC57-Simple vector and then further subcloned into pGEX-6P-1
vector (Sigma-Aldrich). pGEX-6P-1-mPRMT8-54 was transformed into
Rosetta (DE3) pLysS (Novagen) and transformants were tested for GST-
mPRMT8-54 overexpression. The fusion protein was purified via GST
affinity chromatography and a subsequent desalting step on Bio-Rad
PROFINIA Automated Affinity Purification System. PreScission Pro-
tease (GE Healthcare), provided as 2 units/l in storage buffer (50 mM
Tris-HCl, 150 mM NaCl, 10 mM EDTA, 1 mM DTT, pH 8.0, 20% glyc-
erol), was used to digest GST-mPRMT8-54 (Mr 32 kDa). Purity and
homogeneity of the mPRMT8-54 peptide preparations was investigated
using SDS-PAGE analysis with Coomassie staining. Immunization of
two rabbits (rabbit 1341032 and 134033) for mPRMT8 polyclonal anti-
body development against the N-terminal Ala2-Glu55 peptide was per-
formed by Covalab. Further details are available upon request. To verify
the specificity of the antibody,we tested the antibody onmouse brain and
spinal cord sections obtained from wild-type and PRMT8 knock-out
animals. We could detect strong nuclear localization of PRMT8 in the
cortex and in Purkinje cells, confirming essentially a previous report
documenting PRMT8mRNA distribution in these tissues (Taneda et al.,
2007).
Immunostaining and confocal microscopy. The mice were killed under
deep ketamine–xylazine anesthesia (ketamine hydrochloride, 110 mg/kg
bodyweight; xylazine [Rompun] 12mg/kg bodyweight) and perfused tran-
scardially with 4% paraformaldehyde in PBS. The spinal cords were dis-
sected and the lumbar segments (L4) were identified using the ribs and
vertebrae as a guide. Spinal cords, L4 spinal nerves, and phrenic nerves were
removed, alongwith the TA and EDLmuscles. Serial transverse sections (25
mthick)were cut from the spinal cords on a cryostat (LeicaCM1850) and
mounted onto gelatin-coated glass slides, which were placed into a20°C
fridgeuntil further use.Nonspecific binding siteswere subsequently blocked
with 1% solution (v/w) made of skimmed milk powder. Spinal cord cross-
sections were incubated overnight at 4°C with anti-PRMT8 (noncommer-
cial, see “PRMT8 antibody” section, VAChT; Synaptic Systems), anti-ChAT
(Merck-Millipore, ab-144p) anti-MBP (sc-13914; Santa Cruz Biotechnol-
ogy), anti-asymmetric di-methyl arginine motif (13522S; Cell Signaling
Technology), anti-GFAP (ab4674; Abcam), and anti-H2AX (AF2288;
R&D Systems) antibodies. The antigen–antibody reactions were visualized
through the use of various fluorescent-conjugated Alexa Fluor secondary
antibodies for 1 h at room temperature. Mounting medium containing
DAPI (H1500, Vectashield; Vector Laboratories) was used before covering
slides. Fluorescence signals were detected in an Olympus BX50 epifluores-
cencemicroscope equipped with a DP70 digital camera (Olympus) or in an
Olympus Fluoview FV10c-W3 compact confocal microscope. Quantifica-
tion of immunohistochemistry results was performed by ImageJ.
Immunoblotting. Total extracts of the spinal cords or NSC34 cells were
prepared by homogenization in RIPA buffer containing protease inhib-
itors. Then, 20 g of protein extract was separated by SDS-PAGE in
4–20% gel (Bio-Rad) and then transferred to Immobilon-P Transfer
Membrane (Millipore). Membranes were probed with anti-BIP
(C50B12; Cell Signaling Technology), anti-H2AX (AF2288; R&D Sys-
tems), anti-asymmetric di-methyl argininemotif (13522S; Cell Signaling
Technology), anti-GFAP (ab4674; Abcam), anti-ChAT (NBP1-30052;
Novus), anti-FUS (IHC-00074; Bethyl), anti-GAPDH (sc-32233; Santa
Cruz Biotechnology), anti-MBP (sc-13914; Santa Cruz Biotechnology),
anti-Tubulin (sc-8035; Santa Cruz Biotechnology), anti-CREB1 (06-
863; Millipore), anti-FLAG (F1804; Sigma-Aldrich), and anti-GFP
(ab290; Abcam) antibodies according to the manufacturer‘s recommen-
dations. Methylated anti-FUS antibodies were described previously
(Sua´rez-Calvet et al., 2016). Quantification of immunoblot results were
performed by ImageJ.
qRT-PCR. qRT-PCR was performed using real-time PCR equipment
(Bio-Rad CFX384 Touch). Gene expression was quantified by the com-
parative CT method and normalized to 36b4 or Ppia expression. Values
are expressed as mean SD of the mean. GraphPad Prism version 5.02
was used for data interpretation. The sequences of the primers are avail-
able upon request.
RNA sequencing (RNA-Seq). The RNA-Seq library was prepared from
five animals per genetic group by using a TruSeq RNA Sample Prepara-
tion Kit (Illumina) according to the manufacturer‘s protocol. Illumina
RNA-Seq was performed using standard procedures at the University of
Debrecen.
RNA-Seq samples were analyzed using an in-house pipeline. Briefly,
the 50 bp raw single-end reads were aligned using TopHat (Trapnell et
al., 2013) to the mm10 genome assembly (GRCm38) and only the
uniquely mapped reads were kept using the “max multihits 1” option;
otherwise, the default parameters were used. Samtools version 1.0 was
used for indexing the alignment files. Coverage density tracks (wig files)
for RNA-Seq data were generated by igvtools with the “count” command
and then converted into tdf files using the “toTDF” option. The aligned
reads were assembled by Cufflinks using default parameters. Genes with
RPKM 1 (at least in one sample) were considered to be expressed.Heat
maps were drawn with the R package pheatmap. Statistically significant
difference was considered as FDR0.1 and FC	 1.5 using Cufflinks.
The raw sequence data have been submitted to the NCBI SRA database
(BioProject: PRJNA359090).
ChIP. ChIP-qPCR experiments were performed as described previ-
ously (Barish et al., 2012) with minor modifications. Briefly, cells were
cross-linked in two steps: (1) disuccinimidylglutarate (DSG) for 30 min
and then (2) 1% methanol-free ultrapure formaldehyde for 10 min at
room temperature. Glycine was added for 5 min at a 125 mM final con-
centration. After fixation, chromatin was sonicated with Diagenode
Bioraptor to generate 200–1000 bp fragments. Chromatin was immuno-
precipitated with antibodies against preimmune IgG (12-370; Millipore)
and CREB1 (06–863; Millipore). The eluted DNA was purified (Min-
Elute; Qiagen) and quantified with Qubit fluorometer (Invitrogen). A
more detailed description is available upon request.
ChIP-Seq analysis. ChIP-Seq analysis was performed as described pre-
viously (Simandi et al., 2016). Briefly, primary analysis of the ChIP-Seq
raw reads was performed using a ChIP-Seq analyze command line pipe-
line (Barta, 2011). The Burrows-Wheeler Alignment Tool (Li and
Durbin, 2009) was used to align the reads to mm10 genome assembly
(GRCm38) with default parameters. MACS2 (Zhang et al., 2008) was
used for predicting transcription factor peaks (q-value0.01). Artifacts
were removed using the ENCODE blacklist (ENCODE Project Consor-
tium, 2012). Genome coverage files (bedgraph files) for visualization
were generated by makeUCSCfile.pl and then converted into tdf files
using igvtools with “toTDF” option. De novo motif discovery was per-
formed on the 100 bp vicinity of the peak summits using findMotifs-
Genome.pl with options “length len 10,12,14,16” and “size 200”
on the repeat-masked mouse genome (mm10r) from HOMER. Integra-
tiveGenomicsViewer (IGV2.3, Broad Institute)was used for data brows-
ing (Thorvaldsdo´ttir et al., 2013) and creating representative snapshots.
Cellular viability assay. Cells were plated at a density of 5000 cells per
well on 96-well plates, differentiated in the presence of retinoic acid for
2 d, and then treated with thapsigargin for 24 h. Cell numbers were
determined by MTT-based colorimetric assay (Roche). Results are rep-
resented relative to the control conditions.
DNA damage repair assay. HeLa-GFP-FUS cells were a kind gift from
Ina Poser. Cells weremaintained inDMEM supplementedwith 10%FBS
and 400 g/ml G418. For micro-irradiation experiments, cells were
plated onto 8-well Ibidi chambered coverslips 2 d before measurements
at a density of 15,000 cells in 300 l of phenol red free DMEM per well.
Medium was changed for DMEM containing 40 M ADOX. Micro-
irradiation studies were performed on a Zeiss LSM 880 confocal laser
scanning microscope. Briefly, 20 min before the irradiation, cells were
presensitized with 2 g/ml HOECHST 33258 dye. A 150
 1 pixel (step
size: 70 nm) ROI inside the cell nucleus was selected and micro-
irradiated by a 405 nm diode laser at 100% intensity (32 W at the
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objective) using the bleach function of ZEN software with 8 iterations
and 33 s pixel dwell time, resulting in a total delivered energy of 8.44
nJ/pixel. Cells were scanned before and immediately after micro-
irradiation and then a time series of images was recorded with 30 s inter-
vals for 5 min. We used FiJi Software for subsequent data analysis. The
fluorescence intensity ratio characterizing the enrichment ofGFP-FUS in
the micro-irradiated ROI was calculated by determining the average flu-
orescence intensity per pixel for GFP-FUS in the ROI and dividing this
value with the average pixel intensity detected in the whole cell.
Statistical analysis. Results are presented as the mean  SEM. Com-
parisons between two groups were performed using Student’s t test for
unpaired data. A p-value of 0.05 was considered significant. All data
were analyzed using GraphPad Prism software.
Study approval. All animal study protocols were approved by the An-
imal Care and Protection Committee at theUniversities of Debrecen and
Szeged and were performed in accordance with the European Commu-
nity Council Directives.
Results
ADMA level is restricted to postmitotic spinal cord MNs
Biological functions of arginine methylation have been previously
studied mostly in the context of aberrant cellular proliferation, in-
cludingmany types of cancers (for review, seeWei et al., 2014; Pou-
lardetal., 2016).Therefore, the functionofargininemethylationand
the enzymes producing it remain largely uncharted in terminally
differentiated, postmitotic cells. Comparing total levels of asymmet-
ric and symmetric arginine dimethylation of highly proliferating
embryonic stem cells (ESCs) versus brain or spinal cord tissues
derived from 2-week-old (juvenile), 1-month-old (early adult), and
3- or 6-month-old (adult) mice revealed that the level of ADMA,
catalyzed by type I methyltransferases, was greatly reduced during
early embryonic development and further decreased in the transi-
tion from juvenile to adult stage (Fig. 1A). FUS, a well established
substrate of asymmetric arginine methyltransferases (Dormann et
al., 2012; Scaramuzzino et al., 2013; Scekic-Zahirovic et al., 2017),
also showedreduction in its argininemethylation level asdetectedby
a methylated FUS-specific antibody (Dormann et al., 2012) (Fig.
1A). These changes in the ADMA and Met FUS levels were more
pronounced in the spinal cord (Fig. 1A). In contrast, symmetric
arginine dimethylation, detected by SYM11 antibody, was relatively
constant between the compared stages (Fig. 1A).
Further immunohistochemistry analysis showed that, whereas
many cells, including GFAP astrocytes, show strong staining for
ADMA in the spinal cord of 2-week-old and 1-month-old mice;
ADMA signal become restricted to very few cells by 3months of age
(Fig. 1B). These results suggest that the low abundance of total
ADMAinadultmice is not due touniformly reduced levels of asym-
metrically dimethylated proteins in the various cell types. In fact,
ADMA signals detected in total spinal cord lysates appears to be
derivedmostly fromChATMNs(Fig.1C).Thesepostmitotic cells,
representing only a small percentage of all the spinal cord cells,
showed strong ADMA staining in their nuclei (Fig. 1C). Strikingly,
methylatedFUSalso showed similarneuron-restricted expression in
the spinal cord of 6-month-old mice (Fig. 1C).
We hypothesized that spinal cord ADMA level would likely de-
crease in certain neurodegenerative diseases such as ALS simply due
to the gradual decrease in the number of ADMA MNs with the
disease progression. To test this, we compared ADMA levels in spi-
nal cord samples of control and mutant G93A-SOD1 transgenic
mice and found that ADMA level was indeed decreased in the end
stage (Fig. 1D), further confirming that MNs could be the primary
source of ADMA detected in total tissue lysates.
Inhibition of methyltransferase activity induces
accumulation of unrepaired DNADSBs and decreases cell
viability
The striking cell-type-restricted distribution of ADMA in adult
spinal cord raised the question of whether the residual ADMA is
required for viability ofMNs and their response to external stim-
uli. To address this question, we used retinoic acid-differentiated
NSC34MN cells and treated themwith previously describedmeth-
yltransferase inhibitor ADOX. Untreated NSC34 cells showed high
ADMAlevel,whichwas completelydiminishedbyADOXtreatment
(Fig. 2A). In parallel, ADOX-dependent inhibition of methyltrans-
ferase activity resulted ingradual accumulationofBIP(markerofER
stress), H2AX (marker of unrepaired DNA DSBs), and cleaved
form of Caspase-3 (marker of apoptosis), implicating methyl-
ation in the control of ER stress and in the maintenance of
genome and cellular integrity (Fig. 2A,B). Consistent with
this, cellular viability and stress resistance was also decreased
in ADOX–treated cells (Fig. 2C).
Previous studies extensively documented the role of arginine
methyltransferases in gene expression regulation in various cel-
lular contexts (Lee and Stallcup, 2009). As part of the normal
stress response upon brain or spinal cord injury, the activation of
immediate early genes (IEGs) (e.g., Ier2, Fos,Myc, Egr1, Atf3) has
a pivotal role (Minatohara et al., 2015). Dysregulated control of
these genes has been linked to decreased synaptic plasticity of
neurons in Alzheimer’s disease, ALS, and frontotemporal de-
mentia (FTD) (Lederer et al., 2007; Seijffers et al., 2014; Minato-
hara et al., 2015), suggesting a general involvement of these genes
in neurodegenerative diseases. To test the role of arginine meth-
ylation in transcriptional response of MNs, we pretreated differ-
entiated NSC34 cells with ADOX and then treated the cells with
thapsigargin or sodium arsenite for 3 h to elicit ER stress or oxi-
dative stress, respectively. Pretreatment with methyltransferase
inhibitor reduced the stress-mediated induction of many IEGs
(e.g., Ier2, Egr1, Atf3), as well as other stress-activated gene tran-
scription (e.g., Hspa1b), indicating a broad dysregulation of the
stress-induced neuroprotective gene networks (Fig. 2D).
Overall, these results demonstrate the spatiotemporal pres-
ence of ADMA in the developing spinal cord and cell-type-
restricted occurrence in the adult MNs. Considering the general
effect of ADOX on methylation processes, these results also pro-
vide hints regarding the potential role of arginine methylation in
the regulation of cellular stress tolerance.
PRMT8 is a tissue-specific arginine methyltransferase in
spinal cordMNs
To mechanistically characterize the role of asymmetric arginine
dimethylation inMNs, we decided to identify the arginine meth-
yltransferases expressed in MNs. First, we compared the expres-
sion of known PRMTs during MN differentiation. Reanalysis of
transcriptomic data obtained during direct reprogramming of
mouse embryonic stem cells to MNs (Mazzoni et al., 2013) re-
vealed the high expression of Prmt1 at each stage (Fig. 3A). Inter-
estingly, its closest homolog, Prmt8 (Lee et al., 2005), showed
robust induction in the differentiating MNs (Fig. 3A). Human
PRMT8 expression showed similar induction along the differen-
tiation of human iPSCs to MNs (Fig. 3B). In addition, reanalysis
of gene expression data fromHo et al. (2016) and comparison of
PRMT8 expression in total human spinal cord versus LCM-isolated
MNs confirmed the relative enrichment of PRMT8 in MNs over
other cell types of the human spinal cord (Fig. 3C), whereas PRMT1
expressionwasmore robust in undifferentiated humanESCs.Over-
all, these findings, partially based on previously published human
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Figure 1. Asymmetric arginine dimethylation is highly abundant in postmitotic spinal cord MNs. A, Immunoblot analysis of FUS, methylated FUS, symmetric (SYM11) and asymmetric (ADMA)
arginine dimethylated protein levels in ESCs versus spinal cord samples derived from 2-week-old (2w) to 6-month-old (6m) mice. Representative result of at least three independent immunoblot
analyses and its quantification are shown. Note that FUS in ESCs show slightly different molecular weight. B, Coimmunostaining of mouse spinal cord cross sections derived from 2-week-old,
1-month-old, and 3-month-old animal for ADMA-containing proteins and GFAP (astrocyte marker). Magnification of a region marked by yellow star on the section of the 1-month-old sample is
shownbelow thepanel. Representative results of at least three independent analyses and their quantification are shown. Scale bar, 25m.C, Coimmunostainingof spinal cord cross sections derived
from 6-month-old mouse for ADMA-containing proteins, methylated FUS (Met FUS), and ChAT (MNmarker). Representative results of at least three independent analyses are shown. Scale bar, 25
m.D, Immunoblot analysis ofADMA levels inG93ASOD1 transgenic (S) and control (N)mice (n4 ineachgroup).Onset agesof thediseaseweredeterminedas the timewhen theanimals reached
peak bodyweight and the end stage of the diseasewere determinedwhen the animals could not right themselveswithin 10 swhen placed on their side (typically 12–15weeks). Data are presented
as mean SEM. **p 0.01 (Student’s t-test).
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and mouse transcriptomic data, led us to focus on PRMT8 and
further investigate its role in the CNS for two reasons: (1) cell-
restricted expression of Prmt8 indicated a unique role of this
argininemethyltransferase in adult spinal cordMNs and (2) cell-
type-selective expression of Prmt8makes it a potentially exploit-
able target for therapeutic interventions.
To characterize the cellular localization and distribution of
PRMT8 protein, we developed an antibody against mouse
PRMT8 (see Materials and Methods for more details). PRMT8
expression was restricted to a subset of cells in the spinal cord at
all studied ages (2 weeks to 12 months) (Fig. 3D,E). PRMT8
costaining with ChAT showed the presence of PRMT8 in mouse
spinal cordMNs and revealed its predominantly nuclear localiza-
tion (Fig. 3E).
Next, we sought to understand the regulation of cell-type-
restricted PRMT8. MN cell identity and cell-type-specific gene
expression appears to be strictly coordinated by lineage-specific
transcription factors [e.g., by LHX3, ISL1 (spinal MNs) or LHX3
andPHOX2A (cranialMNs) Sockanathan and Jessell, 1998;Maz-
zoni et al., 2013]. Analysis of ChIP-Seq data obtained from ESC-
derivedMNs (Mazzoni et al., 2013) and fromour previous report
(Simandi et al., 2015) revealed that PRMT8 is likely under the
control of RAR:RXR, LHX3, PHOX2A, and ISL1, providing the
basis of its cell-type-specific expression (Fig. 3F).
Cell type-restricted expression of PRMT8 led us to investigate
the consequences of disease-related loss ofMNs to the expression
of PRMT8. Using the same sample set as shown in Figure 1D, we
found that the PRMT8 level significantly decreased in the end
stage, further supporting the notion that predominantly MNs
express PRMT8 (Fig. 3G).
PRMT8-null animals show progressive muscle atrophy and
NMJ fragmentation
To elucidate the role of PRMT8 in vivo in spinal cord MNs, we
used a knock-out line generated by the European Conditional
Mouse Mutagenesis Program and Knock-out Mouse Project
(EUCOMM/KOMP). As described recently, these animals are
viable, suggesting that PRMT8 per se is not required for the de-
velopment of the CNS (Kim et al., 2015; Simandi et al., 2015).We
validated the knock-out by PRMT8 immunostainings of the spi-
nal cord and various brain regions (Fig. 4A) and also byWestern
blot (Fig. 4B). To assess the motor function of mice, we used 3-,
6-, and 12- to 15-month-old littermate control and PRMT8-null
animals. A limb-clasping test revealed that PRMT8-null animals
Figure 2. Inhibition ofmethyltransferase activity induces accumulation of unrepaired DNA DSBs. A, Immunoblot analysis of BIP (ER stress), cleaved CASP3 (apoptosis), FUS/Met FUS, ADMA, and
H2AX (DNADSB) in differentiated NSC34 cells treatedwith themethyltransferase inhibitor ADOX (40M) for the indicated times. Representative results of at least three independent immunoblot
analyses and their quantification are shown. B, Immunostaining ofH2AX in cells treated with ADOX for 24 h (40M). Representative cells were chosen to show at high magnification. Scale bar,
5m. C, Cellular viability of NSC34 cells measured by MTT assay. Differentiating cells were pretreated with ADOX for 24 h (40m) at day 3 and then subjected to thapsigargin (ER stress, 0.2M)
for 24 h. Averages of eight biological replicates are shown.D, qRT-PCR analysis of gene expression in differentiatedNSC34 cells pretreatedwith ADOX for 24 h (40m) fromday 3 and then subjected
to thapsigargin (ER stress) or sodiumarsenite (oxidative stress) for 3 h at day 4. Averages of three biological replicates are shown. Data are presented asmean SEM. ns, Nonsignificant, *p 0.05,
**p 0.01, ***p 0.001 (Student’s t test).
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Figure3. PRMT8 is a tissue-specific argininemethyltransferase in spinal cordMNs.A, IGVgenomebrowser viewofRNA-Seqdata comparingexpression levels of type I argininemethyltransferases
along ESC to MN differentiation. RNA-Seq experiment was performed by Mazzoni et al. (2013) and data have been reanalyzed to compare expression levels of type I PRMTs. Data range used for
visualization was set to [0–80] for each track. B, CHAT and PRMT8 expression in human iPSCs vs iPSC-derived MNs as measured by qRT-PCR. Averages of three biological replicates are shown.
C, Relative expression levels of PRMT1 and PRMT8 in human ESCs and iPSCs versus spinal cord and LCM-captured postmortem human MNs. Raw data were obtained from Ho et al. (2016). Fibr,
Fibroblast; Spi C, spinal cord. D, Coimmunostaining of spinal cord cross-sections derived from 2-week-old, 3-month-old, and 6-month-old mice for PRMT8 and GFAP (astrocyte marker). Represen-
tative results of at least three independent analyses are shown. Scale bar, 25m. E, Immunostaining of spinal cord cross sections derived from6-month-oldmouse for PRMT8 andMNmarker ChAT.
Scale bar, 25m.F, Occupancyof LHX3, ISL1, andPHOX2A transcription factors in theproximity ofPrmt8encodinggeneasdetectedbyChIP-Seq. Primary ChIP-Seqdatawereobtained fromMazzoni
et al. (2013). Previously described (Simandi et al., 2015) retinoic acid response element (RARE) in the proximity of the transcription start site (TSS) is also marked with a red box. G, Immunoblot
analysis of PRMT8 in G93A SOD1 transgenic (S) and control (N)mice (n 4 in each group). Samples are identical to the ones shown in Figure 1D. Quantification of relative PRMT8 levels in the onset
and end stages are shown. Data are presented as mean SEM. ns, Nonsignificant, *p 0.05, **p 0.01, ***p 0.001 (Student’s t test).
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Figure4. AgedPRMT8-nullmicedevelopmuscleweakness andprogressive fragmentationofNMJs.A, Immunostainingof spinal cord (anterior horn), cortex, and cerebellum isolated fromcontrol
and PRMT8-null mice for PRMT8. Scale bars, 100m. B, Immunoblot analysis of PRMT8 in brain samples of control and PRMT8 knock-out mice. Further details on antibodies PP1 and PP13 are
presented in theMaterials andMethods.C, Control animals at 15months of agehavenormal limb reflexeswhen suspendedby the tail,whereas age-matchedPRMT8-null animals showanabnormal
and weak limb clasping (n 6 in each group). Scoring is based on Guyenet et al. (2010). See also Movies 1 (ctrl) and 2 (PRMT8 knock-out). D, Comparison of maximal Ca 2-activated force levels
of single isolated EDLmyocytes. Force development during isometric contractionswasmeasured in fast skeletalmuscle fibers fromEDLmuscles of 3- and 12-month-old control andPRMT8-nullmice
(n 5 in each group). E, Muscle weight loss in TA and EDLmuscles of aging animals (n 5 in each group). Note the significantmuscle weight loss in 12-month-old PRMT8-null animals compared
with their age-matched controls.F, qRT-PCR analysis ofmuscle atrophymarker Fbxo32. Total RNAwas extracted fromTAand EDLmuscles of 3- and12-month-old control andPRMT8-nullmice (n
8–16 in each group). G, Electron microscopic ultrastructural analysis of 3- and 12-month-old control and PRMT8-null TA and EDL muscles. Shown are normal structure of a control (Ea) and
PRMT8-null (Eb) TA muscles; also shown is a TA muscle sample taken from the 12-month-old control animals (Ec). Note that there is no obvious difference compared with 3-months samples (Ea).
Ed is a TAmuscle sample taken from12-month-old PRMT8-null animals. Note the obviousmorphological changes including uneven sizes and a fuzzy appearance of the cross-striation pattern of the
sarcomers, enlarged mitochondria, and occasional loss of Z discs. The presumed location of a missing Z disc is marked by asterisks. Ee, Ef, Disintegrated structure of EDL muscles taken from
12-month-old PRMT8-null animals. Note the enlarged mitochondria (arrows), uneven staining density of fibers, and splitting myofibrils (asterisks) in Ee. Ef shows a (Figure legend continues.)
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show decreased motor performance, which was more pronounced
in 12-month-oldmice (Fig. 4C,Movies 1 and 2).Muscle forcemea-
surement on isolated muscle fibers revealed that 12-month-old
PRMT8-null animals exhibit decreasedmuscle strength [30.7 3.1
kN/m2 (control) vs 20.6 1.9 kN/m2 (PRMT8-null); Fig. 4D].
Wet muscle weights of control versus PRMT8-null animals
indicated an accelerated muscle weight loss in the knock-out
mice (Fig. 4E). Accordingly, transcriptional levels of Fbxo32
(Atrogin-1) (amuscle atrophy-induced gene) (Bonaldo and San-
dri, 2013) showed a remarkably elevated level in 12-month-old
PRMT8-null animals compared with controls (Fig. 4F), suggest-
ing an extensive atrophy in the muscle of PRMT8-null mice dur-
ing aging.
Next, we used electronmicroscopy to evaluate morphological
changes of themuscle structure. No differences were identified in
young animals; however, lack of PRMT8 resulted in ultrastruc-
tural changes, including disorganized sarcomer structure, un-
even size and staining density of individual fibers andmyofibrils,
enlarged mitochondria, and occasional loss of Z discs and ap-
pearance of splitting myofibrils in 12-month-old animals (Fig.
4G). Numbers of motor units were significantly lower in 12-
month-old PRMT8-nullmice (Fig. 4H).Determination ofmotor
units belonging to control and PRMT8-null TA and EDLmuscles
revealed a significant age-dependent decrease in PRMT8-null an-
imals (EDL: 10.6 1 vs 2.75 1.1, TA: 16.25 1.2 vs 6.25 0.5
in 3 in and 12-month-old animals, respectively, see Fig. 4H),
whereas the number of motor units remained constant in the
12-month-old control animals. Smaller numbers of motor units
produced smaller tetanic forces in 12-month-old PRMT8-null
animals compared with their age-matched controls (PRMT8-
null EDL: 36.5  4.3 cN vs 8.6  1.0cN, wild-type EDL: 37.6 
2.4cN vs 21.2 1.7 cN in 3- and 12-month-old animals, respec-
tively, Fig. 4I), especially in EDLmuscles. Amarked reduction of
tetanic forces was also observed in aging control animals and this
change is likely to be attributable to the aging processes of the
muscle fibers as reported previously (Nair, 2005).
Because Prmt8 is not expressed in the muscle, the observed
age-dependent muscle phenotype is most likely neurogenic due
to loss of PRMT8 in theMNs anddevelops on the basis of reduced
neuromuscular activity (Bu¨tikofer et al., 2011). To test this hy-
pothesis, we next analyzed the number andmorphology ofmotor
end plates in TA and EDL muscles. Several morphological char-
4
(Figure legend continued.) macrophage (M) among the myofibrils of a disorganized muscle
fiber. Scale bars, 1 m. H, Number of motor units as determined by counting the recruited
individual twitch contractions elicited by increasing stimulation of the supplying nerve (n 4
in each group). Note the dramatic loss of functional motor units in both TA and EDL muscles of
PRMT8-null animals. I, Smaller numbers of motor units produced smaller maximum tetanic
forces (cN) inmuscles of aging PRMT8-null animals, especially in the EDLmuscle (n 4 in each
group). J, Histological analysis of NMJs in EDL muscles of 12-month-old animals. Aa, Distribu-
tion of motor end plates and axons in the innervation zone of an intact EDLmuscle. Ab, Various
pathological forms of degenerating NMJs in an EDL muscle. Double arrowhead, right upper
corner: intact-looking NMJ. Hatchmark indicates hypertrophic NMJs; asterisks, fragmented
NMJs; and arrowheads flattenedNMJs. Ac, Higher-magnification viewof two fragmentedNMJs
(asterisks) in an EDL muscle. Small arrows point to axons with bulb-like endings, which do not
belong to motor end plates. Ad, Various forms of sprouting in EDL muscles. Arrows indicate
preterminal sprouting and arrowheads ultraterminal sprouting. Scale bars: Aa, 50m; Ab, 25
m; Ac, 20m; Ad, 10m. K, Quantification of NMJ morphology data. y-axis represents the
percentage of NMJs appearing either pretzel-like (i.e., normal) and pathological NMJs. Note the
high proportion of pathological NMJs in PRMT8-null animals, grouped as fragmented, hyper-
trophic, or flattened. Morphological characterization of NMJ changes was scored based accord-
ing to recent studies (Valdez et al., 2010; Bruneteauet al., 2015). Data arepresentedasmean
SEM. ns, Nonsignificant, *p 0.05, **p 0.01, ***p 0.001 (Student’s t test).
Movie 1. Control animals at 15 months of age have normal limb
reflexes when suspended by the tail.
Movie 2. PRMT8-null animals show abnormal and weak limb
clasping.
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acteristics of NMJs from control and PRMT8-null mice were
assessed. In wild-type animals clusters of NMJs exhibited typical
pretzel-like appearance and they were supplied by regularly ar-
ranged bundles ofmotor axons (Fig. 4J, Aa). In contrast, NMJs of
PRMT8-null mice showed various pathological alterations, in-
cluding hypertrophy, fragmentation, and flattened morphology
(Fig. 4J, Ab,Ac). More than 80% of the NMJs in 12-month-old
knock-out animals were found to be pathological, whereas only
up to 20%ofNMJs were affected in age-matched control animals
(Fig. 4K).
Impaired axonal transport and premature accumulation of
aging pigments inMNs of PRMT8 knock-out animals
We next performed histological analysis of MNs in the lumbar
spinal cord using VAChT-specific antibody. The numbers of
motor neurons (VAChT) in the lumbar ventral horn (L4–
L5) supplying the sciatic nerve decreased in PRMT8-null ani-
mals by 16.8% and 20.7% in 6- and 12-month-old animals
compared with their age-matched controls, respectively (Fig.
5A). Retrograde labeling of the same motor pool with Fast
Blue also revealed a mild decrease (17.4% and 26.8% in 6- and
Figure 5. Age-dependent dysfunction of axonal transport and decreased MN numbers in PRMT8-null mice. A, Left, Representative images taken from cross-sections ofL4 spinal cord segments
showing Fast Blue-labeled and VAChTMNs of a control and PRMT8-null animals at 6 and 12 months of age. Right, Quantification of Fast Blue-labeled and VAChTMNs (n 4 in each group).
Note the moderate loss of VAChT (surviving) MNs and the more severe loss of capacity to retrogradely transport Fast Blue (neurons with lost or degenerating axons) in these neurons. Scale bar,
100m.B, Immunoblot analysis of spinal cord samples taken from12-month-oldmice for ADMA (n3 in eachgroup).C, Electronmicrographs ofMNs from the L4 spinal segment of 12-month-old
control and PRMT8-null mice. MNs show normal ultrastructural morphology but lipofuscin granules (some of the labeled with arrowheads) aremuchmore numerous in the PRMT8-null MNs. Scale
bars: (A): 5m; (B, C): 1m; (D–F): 2m.D, Quantification of autofluorescent signals detected in spinal cord samples of 12-month-old control and PRMT8 knock-outmice. Representative results
of at least three independent analyses are shown. Data are presented as mean SEM. *p 0.05, **p 0.01 (Student’s t-test).
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Figure 6. Age-dependent accumulation of unrepaired DNA DSBs in MNs of PRMT8-null mice. A, Immunoblot analysis of ADMA, CHOP (ER stress), BIP (ER stress marker), GFAP (astrocyte
activation), andH2AX (DNA repair) in spinal cord samples of 3-month-old and 20- to 24-month-old mice. B, Immunoblot analysis of ADMA, BIP, andH2AX. Differentiated NSC34 MN cells were
treatedwith thapsigarginor sodiumarsenite for the indicated times.GAPDHservedasa loading control.Note theunexpectedaccumulationofH2AXuponER stress.C, Immunoblot analysis of spinal
cord samples taken from 12-month-old mice forH2AX (n 3 in each group). D, Immunostaining of spinal cord samples from 12-month-old mice forH2AX. Representative images are shown.
Immunoblot presented in C serves as a quantitative comparison. E, Left,Micro-irradiation-induced FUS recruitment to DNADSBs. HeLa cells expressing GFP-FUS constitutivelyweremicro-irradiated
at 405 nm in a 150
 1 pixel ROI (step size: 70 nm). Right, Comparative analysis of FUS kinetics in control versus ADOX-pretreated cells. Data are presented asmean SEM. ns, Nonsignificant, *p
0.05, **p 0.01, ***p 0.001 (Student’s t test).
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Figure 7. Compromised CREB1-dependent activation of stress signaling pathways.A, RNA-Seq analysis of spinal cord samples isolated from6-month-old control and PRMT8-nullmice (n 5 in
each group). B, C, Prediction of PRMT8-dependent molecular and cellular functions and upstream regulators using IPA based on RNA-Seq data obtained in control and PRMT8-null spinal cord
samples.D, ChIP-qPCR validation of CREB1 binding in differentiated NSC34 cells. E, Analysis of siCREB1 efficiency by immunoblot. Differentiating NSC34 cells were transfected and incubated for 2 d.
F, qRT-PCR analysis of Creb1and target gene expression in CREB1-depleted cells upon thapsigargin-induced stress.G, Immunoblot analysis of spinal cord samples taken from 12-month-old control
and PRMT8-null animals for CREB1 (n 4 in each group). H, Immunoblot analysis of CREB1 in ADOX-treated differentiated NSC34 cells. I, Changes of CREB1 protein (Figure legend continues.)
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12-month-old animals, respectively), suggesting an impaired
axonal transportin PRMT8-null animals (Fig. 5A, right).
Overall, these data suggested that more than one-fourt of ag-
ing MNs were defunct in 12-month-old PRMT8-null mice.
The relatively mild impacts of PRMT8 depletion on the num-
ber of MNs led us to investigate whether loss of PRMT8 is
associated with decreased ADMA level and if these cells are
intact. Immunoblot comparison revealed decreased arginine
methylation (Fig. 5B), suggesting that, even if other type I
arginine methyltransferases (e.g., Prmt1) are expressed in
adult spinal cord MNs, loss of Prmt8 is not fully compensated
by them.
Electron microscopy revealed premature accumulation of
abnormal amount of lipofuscin in the MNs (Fig. 5C). Further
analysis quantitatively confirmed the increased level of autofluo-
rescent aging pigments in the PRMT8 knock-out spinal cord
MNs (Fig. 5D), a pathological change that also appears prema-
turely in ALS patients (McHolm et al., 1984).
Accumulation of DNADSBs inMNs of aged
PRMT8-null animals
Arginine methylation has been previously linked to DNA DSB
repair in proliferating cells (Yu et al., 2009, 2012) and, according
to our data, the ADOX-treated NSC34 cells showed accumula-
tion of H2AX (Fig. 2B). Recent findings in neurodegenerative
diseases revealed that even small changes in the machinery of
DNA repair can affect the age of onset of neurodegeneration,
raising the possibility that compromised DNA repair is a com-
mon risk in the progression of such diseases (Madabhushi et al.,
2014). Comparison of spinal cord tissues isolated from 3-month-
old and 24-month-old mice revealed the increased level of
H2AX, as well as presence of CHOP (ER stress marker) and
increased GFAP level (astrocyte activation) in aging mice, likely
as consequences of aging-associated stress (Fig. 6A). ADMA level
showed amild reductionwith aging (Fig. 6A). To test howADMA
level changes upon stress in in vitro conditions, we treatedMN cells
with thapsigargin (ER stress) and sodium arsenite (oxidative stress).
Strikingly, persistent ER stress or oxidative stress reduced total
ADMA levels and in parallel inducedDNADSB response (H2AX)
(Fig. 6B). To determinewhether loss of PRMT8may lead to prema-
ture accumulation of DSBs in spinal cord MNs, we compared
H2AX levels. Immunoblot analysis revealed an increased H2AX
level in 12-month-old PRMT8 knock-out mice, indicating insuffi-
cient DNA repair (Fig. 6C). Immunohistochemistry confirmed the
accumulation of H2AX cells in the PRMT8 knock-out spinal
cords, but not in age-matched controls (Fig. 6D).
Previous studies already proposed the role of arginine meth-
ylation in DNA repair in proliferating cells. Importantly, themu-
tant form of FUS, in which the mutation affects the arginine
methylated site, results in impaired DSB repair (Wang et al.,
2013).Using aGFP-FUS-expressing stable cell line, we confirmed
the dynamic recruitment of FUS to micro-irradiation-induced
DSBs (Fig. 6E). Moreover, we found that ADOX pretreatment of
the cells strongly increased the residence time of FUS at the sites
of DSBs, indicating impaired function and altered kinetics of
hypomethylated FUS (Fig. 6E). Collectively, these data suggest
impaired DNA DSB repair in aging PRMT8-null animals.
Loss of PRMT8 disrupts the CREB1-dependent
neuroprotective transcriptional network
In previous studies, profiling of gene expression has been widely
used in MN disease models at several stages during the course of
disease and revealed early gene expression changes related to in-
flammation, apoptosis, ATP biosynthesis, myelination, axonal
transport, and synaptic transmission (de Oliveira et al., 2013;
Scekic-Zahirovic et al., 2016). To identify components affected in
spinal cords of aged PRMT8-null animals in an unbiased man-
ner, we applied RNA-Seq on total RNA extracted from the lum-
bar spinal cord regions of five mice per group. We considered
those genes differentially expressed that showed at least 1.5-fold
change in their expression at least in 4 mice per group. As ex-
pected, Prmt8 expression was completely diminished in the
knock-out mice (Fig. 7A). Several genes with well established
roles in myelinization (e.g., Mpz, Prx) were dysregulated (Fig.
7A). Genes involved in synaptic plasticity (Nrgn, Syt5, Sst,Camkv,
Gabra2) and cellular metabolism (Ch25h, Igfbp6) were also de-
creased in PRMT8-null mice (Fig. 7A). The list of dysregulated
genes included many genes previously shown to be differentially
expressed in human ALS or FTD (e.g., Nrgn, Gabra2, Hspa1b,
Gucy1a2) (Lederer et al., 2007; Comley et al., 2015) and several
IEGs (e.g., Atf3, Egr1, Ier2). Pathway analysis of differentially
expressed genes by ingenuity pathway analysis (IPA) indicated
DNA replication, recombination, and repair as one of the top
cellular function affected in PRMT8 knock-out tissues (Fig. 7B),
consistent with the accumulation of H2AX detected in spinal
cord lysates of PRMT8 knock-out mice (Fig. 6). To better under-
stand the molecular mechanisms impaired in PRMT8-depleted
MNs, we used IPA to predict potential upstream transcriptional
regulators causing dysregulated gene expression. This analysis
revealed that the function ofCREB is likely affected in the absence
of PRMT8 (Fig. 7C).
CREB1 is a constitutively expressed transcription factor that
regulates the expression of genes involved in neuronal survival
and function (Sakamoto et al., 2011). To assess whether CREB1
directly regulates the genes differentially expressed in the spinal
cord of PRMT8-null mice (e.g., Atf3, Nr4a1, Egr1, Ier2; Fig. 7A),
we analyzed binding of CREB1 in the proximity of their tran-
scription start site by ChIP-qPCR. These results confirmed that
CREB1 is enriched at these sites (Fig. 7D). The requirement of
CREB1 for the induction of these IEGs upon cellular stress was
validated by loss-of-function experiments in differentiated
NSC34 cells (Fig. 7E,F).
To understand why the CREB1-dependent gene expression
network is dysregulated in PRMT8-null mice, we next analyzed
CREB1 at the protein level. This comparison revealed a reduction
of CREB1 protein levels in in vivo in 12-month-old PRMT8
knock-out spinal cord samples (Fig. 7G). Comparison of CREB1
levels following inhibition ofmethyltransferase activity byADOX
confirmed a gradual decrease in CREB1 protein levels (Fig. 7H),
formally suggesting that arginine methylation is required to
maintain CREB1 level. Exposing NSC34 cells to persistent stress
also reduced the level of CREB1 (Fig. 7I) in addition to reducing
the ADMA level (Fig. 6B), suggesting a positive correlation be-
tween the level of ADMA and CREB1.
We next wanted to determine whether ectopic expression of
PRMT8 or CREB1 is sufficient to increase cell survival and stress
4
(Figure legend continued.) level upon ER stress (thapsigargin, 1 M), oxidative stress (so-
dium arsenite, 0.2M), and DNA DSB induction (etoposide, 5M). Representative results of at
least three independent experiments are shown. J, Immunoblot analysis of ADMA level in
control versus CREB1-overexpressing NSC34 cells. Representative results of at least three inde-
pendent immunoblot analyses and their quantification are shown. K, Cellular viability of
PRMT8-depleted cells transfected with GFP (control) or CREB1 as measured byMTT assay. Data
are presented as mean SEM. ns, Nonsignificant, *p 0.05, **p 0.01, ***p 0.001
(Student’s t test).
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tolerance. Overexpression of CREB1 failed to increase the level of
ADMA, suggesting that mechanistically PRMT8 is upstream of
CREB1 (Fig. 7J). However, restoration of CREB1 levels could
increase the stress tolerance and survival rate of PRMT8-depleted
MNs (Fig. 7K). Together, these results indicate that overexpres-
sion of CREB1 or wild-type PRMT8 results in a cellular pheno-
type with increased stress tolerance.
Discussion
Tissue integrity in multicellular organisms is highly dependent on a
coordinated response to external and internal insults during aging
and disease processes. Recent findings suggest that stress response
signaling can be manipulated and altered to extend life span and
delay the onset of age-related pathologies such as neurodegenerative
diseases, suggesting an entirely new therapeutic approach for these
degenerative disorders (Epel and Lithgow, 2014). Therefore, identi-
fication of tissue- and cell-type-specific regulators of stress response
is of great interest and holds therapeutic potential. It would be of
particular relevance to determine whether if tissue-specific mecha-
nisms and ones selective to postmitotic states could be uncovered
and targeted safely in aging and disease. As part of our systematic
analysis of neural differentiation, we have identified such a mecha-
nism and a protein responsible for that. Here, we show that PRMT8
is highly and selectively expressed in postmitotic spinal cord MNs
Figure8. PRMT8provides cellular stress tolerance inagingMNs.ADMAprovidesprotectionagainst age-relatedaccumulationofDNAdamageandcell death inpostmitotic neurons. Loss of PRMT8
results in accumulation of DNA DSBs, decreased level of CREB1, and dysregulated activation of IEGs in aging cells. As a consequence, loss of synaptic plasticity, NMJ fragmentation, and eventual loss
of MNs occur at a premature age.
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and, although it is not essential for their differentiation per se, it acts
as a keymodulator of the stress tolerance and plasticity of these cells
by enabling CREB1-dependent transcriptional activation of IEGs
andDNAdamage response inducedasprotectivemechanisms in the
aging tissues. These findings provide several important insights that
will help us to better understand commonmechanisms of aging and
neurodegeneration-related pathologies.
First, despite extensive research, initialmechanisms leading to
aging or disease-related progressive loss of MNs remain largely
unknown. An emerging concept on the field ofMNdiseases is the
existence of a “dying-back” process (Cavanagh, 1964; Fischer and
Glass, 2007; Dadon-Nachum et al., 2011). The extensive neuro-
pathological analyses presented in this study regarding the aging
PRMT8-null mice support that the pathological process com-
mences at the most distal part of the MN, the NMJ. Accordingly,
the ratio of affected and pathologically alteredmotor end plates is
very high (80% at 12 onths). As the degeneration extends proxi-
mally, the number of surviving (VAChT) MNs decreases by
20.7% and that of those which are able to transport Fast Blue
retrogradely, by 26.8%. These data suggest that 12-month-old
PRMT8-null animals may suffer a loss of only one-fifth of their
sciatic motor pool accompanied by a higher number of degener-
ated or lost axons, but the complete disintegration at the level of
motor end plates renders the muscle atrophic and thus defunct.
This dying-back mechanism of neurodegeneration has been
linked to neuronal loss in many human degenerative and trau-
matic nervous system lesions, including Charcot-Marie Tooth
disease, Alzheimer’s disease, autoimmune diseases (e.g., myas-
thenia gravis), intoxication, or death ofMNs (e.g., spinal muscu-
lar atrophy, ALS; Dadon-Nachum et al., 2011). Age-associated
degeneration can also affect the integrity of NMJs, resulting in
progressive muscle weakness (Coleman, 2005). An important is-
sue is the relevance of PRMT8 function to these human degener-
ative diseases and aging-associated muscle weakness. So far, no
studies have linked PRMT8mutations to any of these neurodegen-
erative disorders, suggesting formally that either PRMT8mutations
have no significant contribution to human disease progression or
PRMT8 is essential for human development and its total loss is in-
compatiblewith life. Indeed, based on theBroad’sHumanKOProj-
ect, thepredictions suggest that loss-of-functionvariants forPRMT8
are not tolerated in humans (Narasimhan et al., 2016). This also
raises important evolutionaryquestions, suggesting thatPRMT8ob-
tained additional functionsduring evolution and it became required
for life in humans. Further experiments in human stem-cell-derived
neurons, including those taken from ALS patients, will be required
to address this possibility adequately.
Second, we discovered a regulatory relationship by which suf-
ficient CREB1 levels are maintained in normal, healthy cells and
regulate cellular plasticity and regenerative transcriptional pro-
gram through the activation of IEGs. CREB is a bona fide neuron
survival factor known to integrate several signaling cascades, in-
cluding a large number of receptors and kinases (Lonze and
Ginty, 2002). Overexpression of dominant-negative CREB mu-
tants causes apoptosis of postmitotic neurons and genetic disrup-
tion of CREB in mice results in axonal growth defects and
perinatal lethality (Lonze and Ginty, 2002). The anti-apoptotic
functions of CREB are only partially understood. CREB-
dependent transcription of prosurvival genes such as Bcl2 and
neuron growth factors has been identified (Lonze and Ginty,
2002). ChIP analysis of CREB1 binding presented in this study
and loss-of-function approaches have extended our knowledge
onCREB1-dependent protective pathways, revealing thatCREB1
regulates the activation of IEGs inMNs. Moreover, CREB1 over-
expression experiments revealed that CREB1 exhibits a neuro-
protective function against oxidative and ER stress in spinal cord
MNs, similarly, as shown previously in the hippocampus (Man-
tamadiotis et al., 2002). PRMT8 is required for the maintenance
of CREB1 levels and this mechanism is likely indispensable for
themaintenance and reinnervation of NMJs during the course of
life. Loss of PRMT8 results in dysregulated activation pattern
of IEGs (e.g.,Atf3,Nr4a1, Egr1) due to the decreased total level of
CREB1. We believe that there is no direct one-to-one molecular
link by which PRMT8 controls protective CREB1 protein levels.
Our results suggest that CREB1 level is generally negatively con-
trolled by persistent stress signals. These findings also explain
previous results showing a downregulation of CREB1 protein in
Alzheimer’s brain (Pugazhenthi et al., 2011). A very likely sce-
nario is that DNA repair mechanisms in PRMT8-depleted cells
are disturbed and the cells accumulate DNA DSBs (reflected by
the increased H2AX level), which in turn reduces CREB1 levels
(similarly to etoposide), leading to cell death. Indeed, previous
studies already linked other PRMTs to the control of DNA dam-
age response (Boisvert et al., 2005a). Further studies will be re-
quired to clarify whether PRMT8 can also modulate DNA DSB
repair mechanisms in postmitotic neurons and, through these
mechanisms, protect them against oxidative-stress-induced
DNA damage and cell death. It is tempting to propose the role of
methylated FUS in this process. Our results confirmed those of
previous studies documenting the recruitment of FUS to DSBs
(Wang et al., 2013) and we found that hypomethylated FUS
showed altered kinetics. Recent studies showed that FUS and
other RBPs create liquid-like compartments at the sites of DNA
damage by liquid demixing (Patel et al., 2015; Kai, 2016). Accord-
ing to our Western blot analysis, treatment with ADOX reduced
the number of methylated FUSmolecules. We could hypothesize
that the formation of these compartments might disturbed by
methylation inhibition,which could reduce the dynamics of FUS.
Alternatively, nonmethylated FUS may bind to sites of DNA
damage with lower affinity; it may also recruit DNA repair en-
zymes with a lower efficiency, whereby the kinetics of the repair
process may become slower. Further studies are needed to clarify
the mechanism of methylation inhibition on FUS function.
An important conclusion of our study is that the predominant
arginine methyltransferase PRMT1, which is ubiquitously ex-
pressed in every tissue, is insufficient alone to maintain genome
integrity and provide stress resistance in aging neurons. PRMT1
displays a high degree of sequence identity to PRMT8, formally
suggesting that these two enzymes have common substrates (e.g.,
FUS; Scaramuzzino et al., 2013) andmay function redundantly in
neurons. Therefore, in postmitotic neurons, one of the most vul-
nerable cell types in our body, the tissue-specific appearance of
PRMT8 in addition to PRMT1 most likely had major evolution-
ary benefits for survival and function over an entire life span.
However, the decreased expression of Prmt1 in postmitotic MNs
versus the rapidly dividing ESCs and the exactly opposite pattern
ofPrmt8 expression (Fig. 3C) suggest that these two enzymesmay
have context-dependent, nonoverlapping functions as well. In
fact, ADMA level significantly decreased in PRMT8 knock-out
mice, suggesting that PRMT1 or other arginine methyltrans-
ferases cannot fully compensate for the loss of PRMT8. Further
studies will be needed to clarify the interrelationship between
PRMT1 and PRMT8 and whether PRMT1 also regulates cellular
stress tolerance of MNs similarly to PRMT8.
In summary, we provide evidence for the existence of a
novel mechanism by which asymmetrical arginine dimethyla-
tion produced by PRMT8 can provide protection against age-
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related cellular stress through maintaining genome integrity
and CREB1-dependent activation of IEGs (Fig. 8). Impor-
tantly, this supports the idea that tissue-specific regulators of
stress response exist and function in mature cells, so cell-type-
specific selective drug targeting may be possible in various
diseases, including enhancement of MN stress tolerance and
consequently life span in neurodegenerative disorders such as
ALS and/or MN disease.
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